Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acetyl-L-carnitine (ALCAR) is an endogenous, acetylated derivative of the amino acid L-carnitine that plays a vital role in cellular energy metabolism and neuroprotection [4, 6]. It is synthesized within mitochondria, where it serves as a substrate for the enzyme carnitine O-acetyltransferase (CRAT) to facilitate the reversible transfer of acetyl groups, thereby maintaining mitochondrial acetyl-CoA homeostasis and supporting the transport of fatty acids for beta-oxidation [11, 16]. Beyond its primary metabolic function, ALCAR provides essential acetyl groups for the biosynthesis of the neurotransmitter acetylcholine and exerts neuroprotective and analgesic effects through the epigenetic modulation of histone acetylation [4, 15]. Clinically, ALCAR is utilized as both a drug and a dietary supplement to treat conditions such as diabetic neuropathy, age-related cognitive decline, and geriatric depression [10, 13]. While generally well-tolerated, exogenous administration can cause side effects like gastrointestinal upset or a fishy body odor and requires caution in patients taking anticoagulants like warfarin or those with a history of seizures [10, 11].
Acetyl-L-carnitine primarily acts as a substrate for carnitine O-acetyltransferase (CRAT), facilitating the transport of acetyl groups across mitochondrial membranes to maintain the acetyl-CoA pool and support fatty acid beta-oxidation. It also serves as an acetyl donor for the synthesis of acetylcholine and mediates neuroprotective effects through antioxidant activity and epigenetic regulation of gene expression, such as the upregulation of metabotropic glutamate receptors.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acetyl-L-carnitine (ALCAR).